Literature DB >> 10619713

A diagnostic fluorescent marker kit for six limb girdle muscular dystrophies.

I Richard1, N Bourg, S Marchand, O Alibert, B Eymard, A J van der Kooi, C E Jackson, C Garcia, J M Burgunder, C Legum, M de Visser, M Fardeau, J S Beckmann.   

Abstract

The autosomal progressive muscular dystrophies which are grouped together under the term limb girdle muscular dystrophies (LGMD) are diseases characterized by a progressive impairment of the proximal limb muscles and myopathic changes on electromyogram and muscle biopsy. Eight independent purely recessive genetic entities have been recognized in this group of diseases by genetic localization or causative gene identification. We have developed fluorescent genetic markers bracketing six of these loci (LGMD2A-LGMD2F). The marker loci were genotyped in 96 LGMD2 families leading to genetic definition of 25 of them either with a high likelihood or with a suggested localization (7 LGMD2A, 5 LGMD2B, 4 LGMD2C, 4 LGMD2D, 2 LGMD2E and 3 LGMD2F). In addition, 18 families were excluded for all six tested loci; for 45 of the 53 remaining families at least one exclusion could be demonstrated. This kit, which makes the rapid genetic testing of LGMD2 families possible, may be useful in a diagnostic process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10619713     DOI: 10.1016/s0960-8966(99)00037-1

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  2 in total

1.  Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes.

Authors:  G Piluso; L Politano; S Aurino; M Fanin; E Ricci; V M Ventriglia; A Belsito; A Totaro; V Saccone; H Topaloglu; A C Nascimbeni; L Fulizio; A Broccolini; N Canki-Klain; L I Comi; G Nigro; C Angelini; V Nigro
Journal:  J Med Genet       Date:  2005-09       Impact factor: 6.318

2.  Calpain-3 mutations in Turkey.

Authors:  Burcu Balci; Stefania Aurino; Göknur Haliloglu; Beril Talim; Sevim Erdem; Zuhal Akcören; Ersin Tan; Melda Caglar; Isabelle Richard; Vincenzo Nigro; Haluk Topaloglu; Pervin Dincer
Journal:  Eur J Pediatr       Date:  2006-01-13       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.